Crimean Congo Hemorrhagic Fever Vaccine (Karolinska Institutet)

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug NameCrimean Congo Hemorrhagic Fever Vaccine (Karolinska Institutet)
Drug Alias NameN-pVAX1
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever, Crimean
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKarolinska Institutet
China Registration ClassN/A

Develop Information

Active CompaniesKarolinska Institutet
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Crimean
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A